Skip to main content
Available COVID-19 Vaccines
5, Jan 2021

COVID-19 Vaccines: Authorized for Emergency Use

Latest Updates: (01/18/2021)

  1. Astra Zeneca vaccine received another approval in Brazil on Jan 17.
  2. A new vaccine called CoronaVac from Sinovac also received approval on Jan 17 in Brazil.

Initial Approvals Matrix:

A quick snapshot of vaccines approved globally for use -

Company Region Authorization Trial Population Efficacy Doses Storage
Pfizer-BioNTech UK 12/2/2020 >40,000 subjects 95% 2 minus 70 degrees C 
  US 12/11/2020        
  EU 12/21/2020        
  WHO 12/31/2020        
Moderna US 12/18/2020 30,000 subjects 94.50% 2 minus 20 degrees C 6 months
  UK 01/08/2021        
Astra-Zeneca UK 12/30/2020 20,000 volunteers      
  Argentina 12/30/2020        
  India 01/02/2021 1600 subjects 62% 2 2 to 8 degrees C (refrigerator)
Bharat Biotech India 01/03/2021 22,500 subjects unknown 2  


Plexision develops cellular biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. We also pioneer in R&D projects centered on integrating biomarker targets in all phases of drug development, from preclinical to post-marketing. Plexision’s technology can be adapted to

  • - Assess disease risk for several immunological disorders.
  • - Predict the success of a drug for a specific patient.
  • - Develop dosing recommendations for new immunological drugs.

Our state-of-the-art laboratory is CLIA-certified and located in Pittsburgh, PA.